| Financial Year |
March 31 2023 |
| Monetary Funds |
15,473,168,152.50 |
| Held-for-trading Financial Assets |
583,193,655.70 |
| Notes Receivable |
38,959,696.72 |
| Accounts Receivable |
7,831,489,847.21 |
| Advances to Suppliers |
1,350,645,866.71 |
| Other Receivables |
719,835,116.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
19,678,020.08 |
| Inventories |
7,630,095,350.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
478,258,518.47 |
| Total Current Assets |
35,179,941,530.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
84,107,793.16 |
| Long-term Equity Investment |
23,095,630,777.71 |
| Investment Properties |
-- |
| Fixed Assetes |
10,251,417,082.85 |
| Under-construction Projects |
5,528,706,501.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
12,585,063,914.61 |
| R&D expenses |
3,291,580,242.13 |
| Goodwill |
10,260,335,039.33 |
| Long-Term Deferred and Prepaid Expenses |
542,158,222.10 |
| Deferred Income Tax Assets |
429,652,907.33 |
| Other Non-Current Assets |
2,892,019,391.57 |
| Sub-Total of Non-Current Assets |
72,199,433,860.80 |
| Total Assets |
107,379,375,391.79 |
| Short-Term Loans |
14,012,819,200.10 |
| Trading Financial liabilities |
-- |
| Notes Payable |
832,042,279.22 |
| Accounts Payable |
5,805,946,950.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,135,746,685.21 |
| Taxes Payable |
872,053,638.79 |
| Interest Payable |
-- |
| Dividend Payable |
33,579,965.75 |
| Other payables |
4,962,627,508.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,678,048,083.99 |
| Other Current Liabilities |
95,046,744.44 |
| Sub-Total of Current Liabilities |
32,468,080,488.92 |
| Long-term Loans |
11,851,681,250.08 |
| Bonds Payable |
499,547,964.85 |
| Long-Term Accounts Payable |
346,629,665.70 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,340,460,904.44 |
| Other Non-Current Liabilities |
2,484,029,434.13 |
| Sub-Total of Non-Current Liabilities |
19,863,580,280.01 |
| Total Liabilities |
52,331,660,768.93 |
| Paid-In Capital(Or Share Stock) |
2,672,156,611.00 |
| Capital Surplus |
16,968,469,974.41 |
| Surplus Reserve |
2,952,929,442.20 |
| LESS:Treasury Stock |
53,254,806.00 |
| Undistributed Profits |
24,236,965,778.39 |
| Minority Stockholder's Interest |
9,654,554,104.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
45,393,160,518.35 |
| Owner's Equity（Stockholder's Equity） |
55,047,714,622.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
107,379,375,391.79 |
